This compound is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate in the development of pharmaceuticals. Its boronic acid functional group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct carbon-carbon bonds in the synthesis of complex molecules, including potential drug candidates.

The presence of the 4-methylpiperazine moiety enhances its utility in designing compounds with improved pharmacokinetic properties, such as solubility and bioavailability. It is often explored in the creation of targeted therapies, particularly in oncology, where boronic acid derivatives are known for their role in proteasome inhibition. Additionally, its structural features make it a candidate for research in neurological and inflammatory diseases, where modulation of specific biological pathways is required.